The potential mechanism might be related to cMyc-regulated enzymes like glutathione (GSH) and phosphoserine phosphatase (PSPH), which promote redox hemostasis for cancer cells and activate the serine biosynthesis pathway (Sun et al., 2015). The gene discussed is MYC; the disease is cancer.